Evidence map›Paper›PMID 27052731›Full record

ArticleMolecular cell2016

SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins.

Mi-Jeong Park, Ren Sheng, Antonina Silkov, Da-Jung Jung, Zhi-Gang Wang, Yao Xin, Hyunjin Kim, Pallavi Thiagarajan-Rosenkranz, Seohyeon Song, Youngdae Yoon and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 86 citations in OpenAlex.

  1. PI(3,5)PScience advances · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genes · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Lipid Binding of SH2 Domains.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 2 countries.

Mi-Jeong ParkDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea.
Ren ShengDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Antonina SilkovDepartment of Biochemistry and Molecular Biophysics and Howard Hughes Medical Institute, Columbia University, New York, NY 11032, USA.
Da-Jung JungDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea.
Zhi-Gang WangDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Yao XinDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Hyunjin KimDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Pallavi Thiagarajan-RosenkranzDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Seohyeon SongDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea.
Youngdae YoonDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Wonhee NamDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea.
Ilshin KimAcademy of Immunology and Microbiology, Institute for Basic Science, Pohang 790-784, Korea.
Eui KimDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea.
Dong-Gyu LeeDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea.
Yong ChenDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Indira SingaramDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Li WangDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
Myoung Ho JangAcademy of Immunology and Microbiology, Institute for Basic Science, Pohang 790-784, Korea.
Cheol-Sang HwangDepartment of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea.
Barry HonigDepartment of Biochemistry and Molecular Biophysics and Howard Hughes Medical Institute, Columbia University, New York, NY 11032, USA.
Sungho RyuDepartment of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea.
Justin LorieauDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.
You-Me KimDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea; Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Korea. Electronic address: youmekim@postech.ac.kr.
Wonhwa ChoDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA. Electronic address: wcho@uic.edu.
University of Illinois Chicago · USPohang University of Science and Technology · KRInstitute for Basic Science · KRColumbia University · USHoward Hughes Medical Institute · US

Funding

Nation Center: Multi-Scale Study- Cellular Networks(RMI)U54CA121852 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2005 to 2015
$37.4M
University of Georgia ProjectU54GM094597 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI ROST, BURKHARD · 2010 to 2014
$36.9M
COMPUTER STUDIES OF PROTEIN STRUCTURE AND FUNCTIONR01GM030518 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HONIG, BARRY H · 1985 to 2020
$4.5M
Membrane Targeting by Phosphoinositide-Binding ProteinsR01GM068849 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHO, WONHWA · 2003 to 2015
$3.9M
High-performance compute cluster for biomedical computingS10OD012351 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2012 to 2012
$2.0M
COMPUTER STUDIES OF PROTEIN STRUCTURE AND FUNCTIONR37GM030518 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HONIG, BARRY H · 1995 to 2004
$1.5M
Regulatory Roles of Cellular CholesterolR01GM110128 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHO, WONHWA · 2014 to 2016
$1.2M
Storage System for High Performance ComputingS10OD021764 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2016 to 2016
$600k
Howard Hughes Medical InstituteNCI NIH HHS CA121852NCI NIH HHS U54 CA121852NIGMS NIH HHS GM030518NIGMS NIH HHS GM094597NIGMS NIH HHS GM110128NIGMS NIH HHS GM68849NIGMS NIH HHS R01 GM030518NIGMS NIH HHS R01 GM068849NIGMS NIH HHS R01 GM110128NIGMS NIH HHS R37 GM030518NIGMS NIH HHS U54 GM094597NIH HHS S10 OD012351NIH HHS S10 OD021764
6 · The paper itself

Abstract

The Src-homology 2 (SH2) domain is a protein interaction domain that directs myriad phosphotyrosine (pY)-signaling pathways. Genome-wide screening of human SH2 domains reveals that ∼90% of SH2 domains bind plasma membrane lipids and many have high phosphoinositide specificity. They bind lipids using surface cationic patches separate from pY-binding pockets, thus binding lipids and the pY motif independently. The patches form grooves for specific lipid headgroup recognition or flat surfaces for non-specific membrane binding and both types of interaction are important for cellular function and regulation of SH2 domain-containing proteins. Cellular studies with ZAP70 showed that multiple lipids bind its C-terminal SH2 domain in a spatiotemporally specific manner and thereby exert exquisite spatiotemporal control over its protein binding and signaling activities in T cells. Collectively, this study reveals how lipids control SH2 domain-mediated cellular protein-protein interaction networks and suggest a new strategy for therapeutic modulation of pY-signaling pathways.

Indexed as

Lipid Metabolismsrc Homology DomainsBinding SitesCells, CulturedHumansJurkat CellsModels, MolecularMolecular Docking SimulationPhosphotyrosineProtein BindingProtein Structure, TertiarySignal TransductionT-LymphocytesZAP-70 Protein-Tyrosine KinasePhosphotyrosineZAP70 protein, humanZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID27052731
PMCPMC4826312
OpenAlexW2311060264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.